Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Regent Partners is an alternative investment firm founded in October 2018, with its headquarters in Seoul, Korea, and an additional office in Seattle, Washington, USA. The firm operates in both venture capital and private equity, focusing on early and growth-stage investments across various sectors, particularly in healthcare and information and communication technology (ICT). Regent Partners was formerly known as CTK Investment and has established a strong presence in the venture capital landscape since its inception.
The firm manages a fund size of $145 million, with a diverse portfolio that includes companies across healthcare, biotech, e-commerce, and AI sectors. Regent Partners has expanded its investment strategy to include middle-market mergers and acquisitions (M&A) and buyout transactions, partnering with companies that demonstrate strong growth potential. The firm is well-positioned to leverage its global networks and investment experience to assist portfolio companies in their growth journeys.
Regent Partners operates with a team of experienced professionals who bring a wealth of knowledge from various sectors. The firm’s dual presence in Korea and the United States allows it to tap into both markets effectively, providing unique opportunities for its portfolio companies. Notable milestones include the establishment of its Seattle office, which enhances its ability to support U.S.-based startups.
Regent Partners invests primarily in early and growth-stage companies, with a strong emphasis on the healthcare and ICT sectors. The firm’s investment strategy encompasses a range of stages, including seed, Series A, Series B, Series C, and growth equity. Check sizes typically range from $270,000 to $6 million, allowing Regent to support companies at various points in their development.
The firm actively seeks out companies that demonstrate strong growth potential, particularly in healthcare and ICT. Regent Partners has expanded its investment focus to include middle-market mergers and acquisitions (M&A) and buyout transactions, indicating a willingness to engage in more complex investment structures. The firm looks for visionary founders who are committed to driving transformative growth within their industries.
Geographically, Regent Partners operates in both South Korea and the United States, allowing it to leverage opportunities in both markets. The firm’s investment thesis combines growth-stage venture discipline with active value creation, focusing on companies that can benefit from Regent’s extensive network and resources. This approach positions Regent as a valuable partner for startups looking to scale and expand internationally.
Regent Partners has built a diverse portfolio that includes notable companies across several sectors:
Sam Chun: CEO of Regent Partners, Sam has a background in finance with experience at BRV Capital Management, Barclays, and SoftBank nPlatform. He holds degrees from New York University Stern and the University of Chicago Booth.
Michael Kim: Senior Managing Director, Michael has a strong background in economics from Johns Hopkins and has worked at BRV Capital Management and Gale International Korea.
Terry Kim: Managing Director, Terry specializes in investment management and has prior experience at Leferi and Samjong KPMG. He holds a degree in business administration from Kyung Hee University.
James Jang: Compliance Director, James oversees compliance and regulatory matters within the firm.
Nathan Park: Vice President, Nathan plays a key role in deal sourcing and portfolio management.
Ryan Koo: Associate, Ryan supports the investment team in various capacities.
Samuel Kim: Venture Partner, EIR & The U.S., Samuel brings extensive experience in venture capital and entrepreneurship.
Francesca Kim: Director of Finance & Accounting, Francesca manages the firm’s financial operations.
Won Jong Rhee: Advisor, Technology, Won provides insights into technology investments.
Jang Wook Choi: Advisor, Technology, Jang supports technology-related investment strategies.
Eui Suk Hwang: Advisor, Healthcare & Europe, Eui offers expertise in healthcare investments.
Young Min Lee: Advisor, Legal, Young provides legal guidance for the firm.
Seonhee Won: Manager, Fund Administration & Finance, Seonhee oversees fund administration and financial reporting.
To pitch to Regent Partners, founders should use the contact form available at https://www.regentpartners.vc/Contact or email directly at regent@regentpartners.vc. It is advisable to include a clear and concise executive summary in the pitch deck, outlining the business model, market opportunity, and growth strategy.
While specific application forms or portals are not disclosed, founders can expect a response time that varies based on the volume of inquiries. Warm introductions may enhance the chances of receiving a timely response, so leveraging connections within the industry could be beneficial.
In September 2025, Regent Partners reported seed funding for MEDISBY, an AI-powered rehabilitation robotic-arm startup, through a fund jointly managed with Yonsei Biohealth Technology Holdings.
In November 2024, the firm invested in Tenstorrent, an AI semiconductor company led by Jim Keller, as reported by Korea Economic Daily.
In June 2024, Regent Partners jointly acquired Dain, a Korean employee-assistance program company, in collaboration with Nudge Healthcare.
Regent Partners also acquired Trost, a healthcare software company, through Wolpeuon, as noted in Korea Economic Daily.
What are Regent Partners' investment criteria?
Regent Partners focuses on early and growth-stage companies, particularly in the healthcare and ICT sectors. The firm looks for companies with strong growth potential and visionary founders.
How can I pitch to Regent Partners?
Founders can pitch to Regent Partners by visiting their contact page at https://www.regentpartners.vc/Contact or by emailing them directly at regent@regentpartners.vc.
What makes Regent Partners different from other investors?
Regent Partners combines growth-stage venture discipline with active value creation, focusing on healthcare and ICT sectors. The firm adds value through its global networks and investment experience, assisting portfolio companies with overseas expansion and management resources.
What is the geographic scope of Regent Partners?
Regent Partners operates primarily in South Korea and the United States, allowing it to leverage opportunities in both markets effectively.
What is the typical check size for investments?
Regent Partners typically invests between $270,000 and $6 million in its portfolio companies, depending on the stage and growth potential of the business.
What is the firm's approach to post-investment involvement?
Regent Partners actively engages with its portfolio companies, providing support in areas such as management resources, joint-venture partnerships, and follow-on funding to help them scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.